🔎 Trials Near Me

ホーム › 下咽頭がん

米国で参加者を募集している下咽頭がんの臨床試験

米国全土の拠点で、下咽頭がんに関する19件の研究が参加者を募集しています。

最も多くの研究がある都市

州別

最近更新された研究

公式研究テキスト（英語）

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06589804

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997068

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT05172245

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

被験者募集中第1相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07156227

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07441681

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

被験者募集中
18歳以上 · 全性別 · 2026/07/16更新 · NCT06662058

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

被験者募集中
18歳以上 · 全性別 · 2026/07/15更新 · NCT01365169

Integrated Cancer Repository for Cancer Research

被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/15更新 · NCT03010150

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

被験者募集中第1相
18歳以上 · 全性別 · 2026/03/04更新 · NCT06868433

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

被験者募集中第2相
18歳以上 · 全性別 · 2026/02/19更新 · NCT07063212

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

被験者募集中第2相
18歳以上 · 全性別 · 2026/02/11更新 · NCT06636734

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

被験者募集中
18歳以上 · 全性別 · 2026/02/10更新 · NCT01473784

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

被験者募集中早期第1相
18歳以上 · 全性別 · 2025/10/22更新 · NCT06914999

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

被験者募集中観察研究
21歳〜90歳 · 全性別 · 2025/09/22更新 · NCT00900419

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。